Last update:

Genetics news

Oncology & Cancer

Hereditary colorectal cancer: Researchers reclassify a large proportion of leading gene variants as benign

The genetic confirmation of a suspected diagnosis of hereditary colorectal cancer is of great importance for the medical care of affected families. However, many of the variants identified in the known genes cannot yet be ...

Genetics

Bioinformatics techniques uncover hidden prevalence of repeat expansion disorders

Research led by scientists at Queen Mary University of London is signaling a new era for genetic sequencing and testing. In the largest study of its kind to date, published today in Nature Medicine, an international group ...

Oncology & Cancer

Categorizing the epigenetic hallmarks that define cancer

Cancer mortality has just surpassed cardiovascular disease for the first time ever and one in two men, and one in three women, will be diagnosed with some form of the disease in the US, according to the NIH.

Genetics

Genetic link between bipolar disorder and epilepsy unveiled

A team of researchers from the Chinese Academy of Sciences has uncovered compelling evidence of a genetic link between bipolar disorder type I (BD-I) and epilepsy, potentially transforming our understanding of these complex ...

Oncology & Cancer

Prostate cancer: Family history, genetics and your risk

If you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of your list. However, learning about your family history and the genetic characteristics of your prostate ...

Oncology & Cancer

Genetic mutations in HRAS, KRAS genes linked to childhood cancers

Hereditary changes in genes are often the cause of rare diseases. For example, disease-causing gene variants (PVs) in the HRAS gene cause Costello syndrome and PVs in the KRAS gene cause Noonan syndrome and cardio-facio-cutaneous ...

Genetics

New clinical CYP3A4 and CYP3A5 genotyping assay recommendations

The Association for Molecular Pathology (AMP) has published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different ...

Oncology & Cancer

Researchers target mutation that leads to pancreatic cancer

After 30 years of discouraging results in attempting to develop drugs to inhibit a mutated protein associated with some of the more challenging cancers to treat, research on RAS proteins is booming.